CEACAM5 and colorectal carcinoma: Of the enrolled patients in S2, 127 had CEA-related cell adhesion molecule 5 (CEACAM5) messenger RNA expression data available; 105 of these patients had MSS-CRC and 45 were in the 100‐ to 160-mg dose cohorts (Fig. 5A).